Esperion Therapeutics reported $65K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amarin AMRN:US $ 294.66M 0.3M
Amgen AMGN:US $ 31343M 96M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Cytokinetics CYTK:US $ 0.08M 0M
Daiichi Sankyo 4568:JP Y 50000M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Esperion Therapeutics ESPR:US $ 65K 4K
Geron GERN:US $ 0.38M 0.05M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Minerva Neurosciences NERV:US $ 0M 0M
Moderna Inc MRNA:US 39.2K 800
Nektar Therapeutics NKTR:US $ 0.02M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
United Therapeutics UTHR:US $ 0.7M 0M
Vanda Pharmaceuticals VNDA:US $ 0.06M 0M